homocysteine has been researched along with semaxinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, MT; Lan, TH; Li, M; Song, JX; Wu, HL; Xu, DP | 1 |
1 other study(ies) available for homocysteine and semaxinib
Article | Year |
---|---|
Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF/p38MAPK and SDF-1/CXCR4 activation.
Topics: Animals; Benzylamines; Cell Movement; Cell Survival; Chemokine CXCL12; Cyclams; Endothelial Progenitor Cells; Ginsenosides; Heterocyclic Compounds; Homocysteine; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |